<html>

<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0,user-scalable=0" />

<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_Footer&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_Footer_Icons&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_InPageMenu&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_MainContent&action=raw&ctype=text/css" />

<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_NavBar&action=raw&ctype=text/css" />
<script type="text/javascript"
    src="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/JS_NavBar&action=raw&ctype=text/javascript">
</script>
<script src="https://2021.igem.org/common/MathJax-2.5-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<style>
    /* CLEAR DEFAULT SETTINGS **************************************************/

    #sideMenu,
    #top_title,
    .patrollink,
    #firstHeading,
    #home_logo,
    #sideMenu {
        display: none;
    }

    #content {
        padding: 0px;
        width: 100%;
        margin-top: 7px;
        margin-left: 0px;
        border: none;
    }

    #bodyContent h1,
    #bodyContent h2,
    #bodyContent h3,
    #bodyContent h4,
    #bodyContent h5 {
        margin-bottom: 0px;
    }

    #bodyContent a[href ^="https://"],
    .link-https {
        padding-right: 0px;
    }

    html {
        height: 100%;
        min-height: 100%;
        font-family: 'Raleway', sans-serif;

    }

    body {
        padding: 0px;
        margin: 0px;
        background: white;

        font-family: 'Raleway', sans-serif;

        display: flex;
        flex-direction: column;
    }
</style>


<body>
    <style>
        #loader-wrapper {
            display: flex;
            align-items: center;
            margin-top: calc((100%)/5);
            justify-content: center;
            height: 0.1vh;
            width: 100vw;
            z-index: 500;
            position: fixed;
            pointer-events: none;
        }

        #loader-bg {
            position: fixed;
            height: 200vw;
            width: 200vw;
            transform: translateY(0);
            background-color: #6C8EC9;
            transition-property: height, width, border-radius, transform;
            transition-duration: 0.5s;
            transition-timing-function: cubic-bezier(.99, .05, .51, 1.01);
            transition-delay: 0s, 0s, 0s, 1s;
            border-radius: 0%;
            -webkit-box-shadow: 0px 0px 27px 0px #6E91CB;
            -moz-box-shadow: 0px 0px 27px 0px #6E91CB;
            box-shadow: 0px 0px 27px 0px #6E91CB;
            justify-content: center;
            align-items: center;
            display: flex;
            flex-direction: column;
            overflow: hidden;
        }


        #loader-wrapper img {
            width: 30vh;

        }

        #loader-wrapper h1 {
            color: #fafafc;
            text-transform: uppercase;
            font-family: 'montserrat-black', sans-serif !important;
            position: absolute;
            transform: translateY(15vh);
            font-size: 2.2vw;
            opacity: 100%;
        }

        #loader-bg.loaded {
            height: 35vh;
            width: 35vh;
            border-radius: 70%;
            transform: translateY(-2000px);
        }
    </style>


    <div id="loader-wrapper">
        <div id="loader-bg">
            <img src="https://2021.igem.org/wiki/images/b/bb/T--Greece_United--loader.gif" />
        </div>
    </div>

    <script>
        // Loader
        window.addEventListener("load", function () {
            let loader = document.getElementById('loader-bg');

            setTimeout(function () {
                loader.classList.add('loaded')
            }, 100);
        });
    </script>




    <div style="display: flex;flex-wrap: wrap;background-color:#002060;position: fixed;top: 0;width: 100%;z-index: 10;">
        <div style="padding: 14px 20px;
        display: flex;
        cursor: pointer;">
            <a href="https://2021.igem.org/Team:Greece_United" class="active">


                <img style="height: 70px;background-size: cover;padding-right: 7px;position: relative;padding-top:20px;"
                    src="https://2021.igem.org/wiki/images/a/a2/T--Greece_United--logo-small-transp-cropped.png">

            </a>
        </div>


        <div class="right-navbar">
            <ul id="nav" style="display: flex;flex-direction: row;list-style: none inside;margin: 0;padding: 0;">

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United'">HOME</a>
                        </button>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Description'">PROJECT</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Description">DESCRIPTION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Implementation">IMPLEMENTATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Results">RESULTS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Contribution">CONTRIBUTION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Partnership">PARTNERSHIP</a> <a
                                onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Fundraising">FUNDRAISING</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Graphics">GRAPHICS</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Design'">WET LAB</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Design">DESIGN</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Engineering">ENGINEERING</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Experiments">EXPERIMENTS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Notebook">NOTEBOOK</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Parts">PARTS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/PartCollection">PART COLLECTION</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Model'">DRY LAB</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model">MODEL</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model/App">APPLICATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model/Circuit">GENETIC CIRCUIT</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Human_Practices'">HUMAN
                            PRACTICES</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Human_Practices">HUMAN PRACTICES</a>

                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Education">EDUCATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Communication">COMMUNICATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Collaborations">COLLABORATIONS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Inclusivity">INCLUSIVITY</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Entrepreneurship'">
                            ENTREPRENEURSHIP</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Entrepreneurship">ENTREPRENEURSHIP</a>


                        </div>
                    </div>
                </li>
                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 17px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Team'">TEAM</a>
                        </button>
                        <div class="dropdown-content">

                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Team">TEAM</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Attributions">ATTRIBUTIONS</a><a
                                onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Sponsors">SPONSORS</a>
                        </div>
                    </div>
                </li>

            </ul>

        </div>
    </div>




    <!-- ---------------------------------------------------- -->
    <!-- ---------------------------------------------------- -->
    <!-- ---------------------------------------------------- -->
    <!-- ------------------- PAGE CONTENT-------------------- -->
    <!-- ---------------------------------------------------- -->
    <!-- ---------------------------------------------------- -->
    <!-- ---------------------------------------------------- -->
    <style>
        /* progress bar */

        #fixedOverlay {
            position: fixed;
            height: 100%;
            width: 100%;
            z-index: 12;
            top: 18px;
            transition: 1s;
            font-family: "montserrat-light" !important;
            /* background-color: #002060; */
        }

        #fixedOverlay[bg=none],
        #fixedOverlay[bg=dark] {
            pointer-events: none;
        }

        #fixedOverlay .scroll-wrapper {
            display: flex;
            position: fixed;
            width: 100%;
            height: 100vh;
            justify-content: space-between;
            opacity: 1;
            transition: 0.5s;
        }

        #fixedOverlay .scroll-wrapper .scroll-area {
            height: 100%;
            width: 5vw;
            display: flex;
            align-items: center;
            justify-content: center;
        }

        @media screen and (max-width: 767px) {
            #fixedOverlay .scroll-wrapper .scroll-area {
                width: 10vw;
            }
        }

        #fixedOverlay .scroll-wrapper .scroll-area#sidebar-wrapper #scrollbar-container {
            width: 30%;
            height: 30%;
            background-color: rgba(98, 129, 239, 0.3);
            border-radius: 10px;
            max-width: 7px;
        }

        #fixedOverlay .scroll-wrapper .scroll-area#sidebar-wrapper #scrollbar-container #scrollbar {
            width: 100%;
            background: #002060;
            opacity: 100%;
            height: 0%;
            border-radius: 20px;
            transition: background-color 0.5s;
        }

        #fixedOverlay nav {
            box-sizing: border-box;
            z-index: 2;
            pointer-events: none;
            display: block;
            transition: 0.5s;
            height: 87px;
        }

        /* back to top */

        #BacktoTop {
            display: none;
            position: fixed;
            bottom: 20px;
            right: 30px;
            z-index: 99;
            font-size: 18px;
            border: none;
            outline: none;
            background-color: #B8EBFF;
            color: white;
            cursor: pointer;
            padding: 15px;
            border-radius: 30%;
        }

        #BacktoTop:hover {
            background-color: #002060;
        }
    </style>

    <script>
        function changeColor(x) {
            x.style.background = '#5893D4';
            x.style.color = '#002060';
        }

        function normalColor(x) {
            x.style.background = '#B7E0FF';
        }
    </script>

    <!-- Back to Top Button -->
    <button onclick="topFunction()" id="BacktoTop" title="Go to top">
        <svg width="24" height="24" viewBox="0 0 24 24">
            <path d="M0 16.67l2.829 2.83 9.175-9.339 9.167 9.339 2.829-2.83-11.996-12.17z" />
        </svg>
    </button>
    <!-- Back to Top Button End-->

    <!-- Progress bar -->
    <div id="globalWrapper">
        <div id="fixedOverlay" bg="none">
            <div class="scroll-wrapper">
                <div id="sidebar-wrapper" class="scroll-area">
                    <div id="scrollbar-container">
                        <div id="scrollbar" style="height: 3%;"></div>
                    </div>
                </div>

            </div>
        </div>
    </div>
    <!-- Progress bar End -->



    <script>
        var textSection = null;
        var navbar = document.getElementById("navbar");

        window.addEventListener('load', function () {
            textSection = document.querySelector('.elevate-navbar');
            checkScrollPos();
            checkBackToTopPos();
        })
        window.addEventListener('scroll', function () {
            updateScrollbar();
            checkNavbarPos();
            checkScrollPos();
            checkBackToTopPos();
        });

        function checkScrollPos() {
            var footerTop = document.getElementById("footerWrapper").getBoundingClientRect().top;
            var scrollbarBottom = document.getElementById("scrollbar-container").getBoundingClientRect().bottom;
            let scrollWrapper = document.querySelector('.scroll-wrapper');
            if (scrollbarBottom >= footerTop) {
                if (scrollWrapper.getAttribute("hiddenScroll") == "false") scrollWrapper.setAttribute("hiddenScroll",
                    "true");
            } else {
                if (scrollWrapper.getAttribute("hiddenScroll") == "true") scrollWrapper.setAttribute("hiddenScroll",
                    "false");
            }
        }

        function checkBackToTopPos() {
            if ($(window).scrollTop() > 1000) {
                $('#backtotop-wrapper').addClass('scrolled')
            } else $('#backtotop-wrapper').removeClass('scrolled')
        }
        $(document).ready(function () {
            $('#backtotop-wrapper').on('click', function () {
                $('html, body').animate({
                    'scrollTop': $('body').offset().top
                }, 2000);
            });
        });

        function updateScrollbar() {
            var winScroll = document.body.scrollTop || document.documentElement.scrollTop;
            var height = document.documentElement.scrollHeight - window.innerHeight;;
            var scrolled = (winScroll / height) * 100;
            document.getElementById("scrollbar").style.height = scrolled + "%";
        }

        var scroll = new SmoothScroll('a[href*="#"]', {
            speed: 400,
            speedAsDuration: true,
            offset: 160
        });

        document.getElementById("fixedOverlay").classList.add("project");
    </script>
    <script>
        function changeColor(x) {
            x.style.background = '#5893D4';
            x.style.color = '#002060';
        }

        function normalColor(x) {
            x.style.background = '#B7E0FF';
        }
    </script>

    <!-- Back to Top Button -->
    <script>
        var mybutton = document.getElementById("BacktoTop");

        window.onscroll = function () {
            scrollFunction()
        };

        function scrollFunction() {
            if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
                mybutton.style.display = "block";
            } else {
                mybutton.style.display = "none";
            }
        }

        function topFunction() {
            document.body.scrollTop = 0;
            document.documentElement.scrollTop = 0;
        }
    </script>

    <!-- header text -->
    <style>
        .header h1 {
            font-size: 50px;
            margin-block-end: 0;
            color: #1F3C88;
            font-family: "raleway", sans-serif !important;
            padding-bottom: px;
        }

        .header h2 {
            margin-block-start: 0;
            font-family: "raleway", sans-serif !important;
            text-transform: uppercase;
            font-size: 30px;
            color: #5893D4;
        }

        .header h3 {
            font-size: 24px;

            margin-block-start: 0;
            font-family: "raleway", sans-serif !important;
            text-transform: uppercase;
            color: #1F3C88;
        }
    </style>

    <div style="margin-top: 200px; padding-bottom:100px;" id="content-tag">
        <div class="contentBlock">
            <div class="content">
                <div class="header">
                    <h1>MARKET ANALYSIS</h1>
                    <h2>Osteoarthritis Evolution</h2>
                </div>
                <p class="content-paragraph">
                    “Osteoarthritis” is derived from the Greek word <b>part osteo-, meaning “bone”, combined with
                        arthritis: arthr-, meaning “joint”, and –itis.</b>
                    <br><br>


                    The disease of osteoarthritis originates from the ancient times. More specifically, the first
                    indications of patients with the disease come from data that has survived from the Pharaonic
                    Egypts and documentation of techniques for spinal manipulation proposed by Hippocrates and the
                    Ancient Greeks. Also, worth mentioning is the fact that Pharaonic Egypts had a popular saying
                    related to osteoarthritis: “Osteoarthritis of the hip for the scribes, vertebral osteoarthritis
                    for the peasants”.
                    <br><br>
                    During the next aeons, doctors have spent countless hours of researching that disease. Until the
                    20th century few were the cases documented, but since medicine developed the cases begun to grow
                    in numbers. More specifically, knee osteoarthritis long existed at low numbers, but since the
                    mid-20th century, the disease has doubled in prevalence.
                    <br><br>
                    The doubling in numbers was the product of the development of a new diagnostic technique, the
                    X-rays. This gave the opportunity for doctors to examine the disease at greater detail and come
                    up with more efficient treatments for osteoarthritis.
                    <br><br>
                    In the past, osteoarthritis was treated by cartilage replacement. More specifically, in 1846 the
                    replacement was done through anaesthesia, in 1865 through cochlear surgery and in 1939 through
                    antibiotics. Nowadays osteoarthritis is treated in various invasive and non-invasive ways. The
                    use of medicines such as paracetamol, anti-inflammatory drugs and duloxetine is essential.
                    Because our project aims to treat knee osteoarthritis, we will now dive into the treatments
                    concerning this specific part of our body. Non-invasive methods, apart from the abovementioned
                    medicines, are physiotherapy, passive gymnastics with electrodes and injection therapy that
                    includes substances such as cortisone or injections of hyaluronic acid and chondroitin into the
                    cartilage. On the other hand, the invasive treatments consist mainly of surgical procedures. The
                    surgical procedures are divided into two main categories: total arthroplasty (the cartilage is
                    removed and an artificial implant is placed) and the partial one-compartment arthroplasty.

                </p>
                <br><br>
                <br><br>
                <div class="header">
                    <h2>Osteoarthritis Industry Analysis</h2>
                    <h3>Treatments</h3>
                </div>
                <p class="content-paragraph">

                    Here in Greece, as in most countries, a patient can be treated on a public or a private hospital
                    depending on the kind of insurance he/she/it has.
                    <br><br><br>

                    <u><b>Surgery</b></u>
                    <br>

                    In the case where the patient has public insurance, the cost is clearly cheaper than in the
                    private sector. The cost varies depending on the case of osteoarthritis (total or partial
                    orthoplasty), the type of implant but also the special CT scans. In this case, the patient being
                    insured with EOPYY pays a specific fee (participation) for the examinations and the surgery is
                    paid by the state. In the case of surgery in the private sector, the patient is asked to pay the
                    difference from his insurance fund. The cost of the surgical team ranges from 1400-2500 €.
                    However, further examinations can reach up to €900. Additional costs are the patient's room of
                    choice (bed) and the length of the patient's stay in the hospital. In the second case of private
                    health insurance, the entire amount (depending on the contract) of the surgery is covered by the
                    relevant insurance company.
                    <br><br>

                    In most public hospitals, simple knee orthoplasty is prevalent. In private hospitals there are
                    more innovative invasive forms, such as robotic knee orthoplasty, Navigation assistance,
                    SuperPath Minimally Invasive Hip Arthroplasty and MIS (Minimally Invasive Method). Due to the
                    year of economic recession in our country but also the high surgical costs in combination with
                    the low salaries, the patients choose the surgery in the public sector. The waiting time for
                    surgery for osteoarthritis starts at 3 months. However, the choice of surgery in the private
                    sector is much more immediate, but costly.
                    <br>
                    <br><br>
                    <u><b>Medications</b></u>

                    <br>

                    Also, a patient can acquire medications that can help relieve osteoarthritis symptoms, primarily
                    pain, with relatively low cost. The most popular choices are:
                    <br><br>

                    <br><b>Acetaminophen:</b> Acetaminophen (Tylenol, others) has been shown to
                    help some people with osteoarthritis who have mild to moderate pain. Taking more than the
                    recommended dose of acetaminophen can cause liver damage. Its cost starts from €10.<br>
                    <br><b>Nonsteroidal anti-inflammatory drugs (NSAIDs):</b> Over-the-counter
                    NSAIDs, such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve), taken at the
                    recommended doses, typically relieve osteoarthritis pain. Stronger NSAIDs are available by
                    prescription. Its cost starts from €15.<br>
                    <br><b>Duloxetine (Cymbalta):</b> Normally used as an antidepressant, this
                    medication is also approved to treat chronic pain, including osteoarthritis pain. Its cost
                    starts from €15.
                    <br><br><br><br>
                </p>
                <div class="header">
                    <h3>Cases of Osteoarthritis</h3>
                </div>
                <p class="content-paragraph">

                    One estimate of the lifetime risk of developing symptomatic knee OA was approximately 40 percent
                    in men and 47 percent in women.

                    The age-standardized prevalence of radiographically confirmed symptomatic knee OA has been estimated
                    at 3.8 percent globally, with rates being higher in women (4.8 percent) compared with men (2.8
                    percent). Knee OA accounts for approximately 80 percent of the disease's total burden, which
                    indicates the importance of our therapy. The prevalence of knee OA in the United States is similar
                    to that of Europe. Fourteen million people in the United States have symptomatic knee OA, with more
                    than half of those with knee OA being younger than 65 years of age. United States data from 2007 to
                    2008 report 7 percent of adults over 25 as having symptomatic knee OA. In 2010, more than 55,000
                    cartilage replacement surgeries were performed in the United States, with 48% of patients over the
                    age of 65.

                </p>
                <br><br>
                <img style="width:85%; align-self: center; "
                    src="https://2021.igem.org/wiki/images/5/56/T--Greece_United--enterp-pic1.png">

                <br><br><br>

                <div class="header">
                    <h3>Cases of Osteoarthritis</h3>
                </div>
                <p class="content-paragraph">

                    The age-standardized prevalence of radiographically confirmed symptomatic knee OA has been estimated
                    at 3.8 percent globally, with rates being higher in women (4.8 percent) compared with men (2.8
                    percent). Knee OA accounts for approximately 80 percent of the disease's total burden, which
                    indicates the importance of our therapy. The prevalence of knee OA in the United States is similar
                    to that of Europe. Fourteen million people in the United States have symptomatic knee OA, with more
                    than half of those with knee OA being younger than 65 years of age. United States data from 2007 to
                    2008 report 7 percent of adults over 25 as having symptomatic knee OA. In 2010, more than 55,000
                    cartilage replacement surgeries were performed in the United States, with 48% of patients over the
                    age of 65.

                    <br><br><br><br>
                </p>

                <div class="header">
                    <h2>Competitors Analysis</h2>
                </div>

                <p class="content-paragraph">
                    <b>Comparative Assessment with Global Alternatives</b><br>
                    The main competitive advantages of Epione
                    method compared to the existing methods is the efficiency of the treatment combined with the
                    non-invasiveness and lack of side effects of the method.
                    <br><br>

                </p>

                <img style="width:85%; align-self: center; "
                    src="https://2021.igem.org/wiki/images/1/14/T--Greece_United--enterp-pic2.png">

                <br><br><br>

                <p class="content-paragraph">
                    <b>Three Similar Offerings</b>

                    <br><br>

                </p>

                <img style="width:80%; align-self: center; "
                    src="https://2021.igem.org/wiki/images/3/30/T--Greece_United--enterp-pic3.png">

                <br><br><br>


                </p>

                <div class="header">
                    <h2>Market Size</h2>
                </div>

                <p class="content-paragraph">
                    Osteoarthritis prevalence rises as the years go by. A study has shown that between the years 1990 to
                    2019, in European countries there is an average increase of 45% in the numbers of patients with
                    Osteoarthritis (see the diagram below). At the same time, in a 2013 report, the World Health
                    Organization, states: “The prevalence of OA is increasing due to population ageing and an increase
                    in related factors such as obesity. According to the United Nations, by 2050 people aged over 60
                    will account for more than 20% of the world’s population. Of that 20%, a conservative estimate of
                    15% will have symptomatic OA, and one-third of these people will be severely disabled. This means
                    that by 2050, 130 million people will suffer from OA worldwide, of whom 40 million will be severely
                    disabled by the disease. Costs associated with OA include costs for adaptive aids and devices,
                    medicines, surgery, and time off at work.
                    <br><br>


                </p>

                <img style="width:80%; align-self: center; "
                    src="https://2021.igem.org/wiki/images/6/62/T--Greece_United--enterp-pic4.png">

                <br><br><br>

                <p class="content-paragraph">
                    Overall, OA caused about 2 million years lived with disability (YLDs) in Western Europe in 2019, a
                    36% increase since 1990. Total years lived with disability attributable to OA in our focus countries
                    in 2019 ranged from 275,405 in Germany to 25,580 in Sweden (a much less populous country). When
                    standardised by population size, the highest rate of disability was in Spain (541 YLD per 100,000)
                    and the lowest in Sweden (367 YLD per 100,000).
                    <br><br>
                </p>

                <img style="width:80%; align-self: center; "
                    src="https://2021.igem.org/wiki/images/5/56/T--Greece_United--enterp-pic5.png">

            </div>
        </div>
    </div>


    <style>
        /* Caption of Modal Image */
        #caption {
            margin: auto;
            display: block;
            width: 80%;
            max-width: 700px;
            text-align: center;
            color: #ccc;
            padding: 10px 0;
            height: 150px;
        }

        @-webkit-keyframes zoom {
            from {
                -webkit-transform: scale(1)
            }

            to {
                -webkit-transform: scale(2)
            }
        }

        @keyframes zoom {
            from {
                transform: scale(0.4)
            }

            to {
                transform: scale(1)
            }
        }

        @-webkit-keyframes zoom-out {
            from {
                transform: scale(1)
            }

            to {
                transform: scale(0)
            }
        }

        @keyframes zoom-out {
            from {
                transform: scale(1)
            }

            to {
                transform: scale(0)
            }
        }

        .out {
            animation-name: zoom-out;
            animation-duration: 0.8s;
        }

        /* Add Animation */
        .modal-content,
        #caption {
            -webkit-animation-name: zoom;
            -webkit-animation-duration: 0.6s;
            animation-name: zoom;
            animation-duration: 0.6s;
        }

        /* 100% Image Width on Smaller Screens */
        @media only screen and (max-width: 700px) {
            .modal-content {
                width: 100%;
            }
        }

        .social-links ul {
            margin: 10% 45%;
            text-align: right;
            display: flex;
            position: absolute;
            transform: translate(-50%, -50%);
            color: rgb(0, 0, 0);
        }

        .social-links ul li {
            list-style: none;
            margin-right: 10%;
        }

        .social-links ul li a {
            text-align: center;
            line-height: 70px;
            font-size: 60px;
            margin: 0 30px;
            display: block;
            position: relative;
            z-index: 1;
        }

        .social-links ul li a .fa {
            position: relative;
            color: rgb(0, 0, 0);
            transition: 0.5s;
        }

        .content p.photo-desc {
            text-align: center !important;
            font-size: 0.8em !important;
        }

        #content-tag {
            background-color: #ffffff;
            position: relative;
        }

        #content-tag p {
            margin: 0;
            font-size: 1.2rem;
            line-height: 1.5;
            margin-top: 20px;
            margin-bottom: 40px;
            text-align: justify;
        }


        #content-tag .contentBlock {
            float: none;
            margin: 0 auto;
        }


        #content {
            padding: 0px;
            width: 100%;
            margin-top: -7px;
            margin-left: 0px;
            border: none;
            line-height: initial;
        }


        .contentBlock {
            width: 64vw;
            max-width: 1200px;
            float: right;
            display: flex;
            flex-direction: column;
        }

        .content {
            padding: 64px;
            border-radius: 5px;
            box-shadow: 0 0 10px lightgray;
            color: #121212;
            margin-top: 40px;
            overflow: hidden;
            display: flex;
            flex-direction: column;
            flex: 1 0 auto;
        }


        .content p:first-child {
            margin-top: 0;
        }


        .content ul {
            padding-inline-start: 20px;
            list-style-image: none;
            list-style-type: none;
        }

        .content ul li {
            display: flex;
            font-size: 1.2em;

        }

        .content ul li::before {
            content: "-";
        }

        .content .splide ul li::before {
            content: unset;
        }

        .content li {
            margin: 10px;
        }

        .content li::marker {
            font-weight: bold;
        }

        .content h4,
        .content h5 {
            font-size: 1.2em;
            text-transform: uppercase;
            margin-block-end: 0.2em;
            margin-block-start: 60px;
        }

        .content h5 {
            font-size: 1em;
        }

        .content a {
            color: #2e64ec;
            text-align: center;
            cursor: pointer;
        }

        .content a.citation {
            font-size: 0.6em;
            vertical-align: super;
        }

        .content-paragraph {
            margin: 0;
            font-size: 1.2rem;
            line-height: 1.5;
            margin-top: 20px;
            margin-bottom: 40px;
            text-align: justify;
        }
    </style>




    <footer class="footer">

        <br><br><br><br>
        <hr style="background-color: #E8E8E8;border: 1.5px solid #E8E8E8;opacity: 50%;">

        <ul>
            <li class="facebook"><a href="https://www.facebook.com/iGEMNous" target="_blank"><i class="fa fa-facebook"
                        aria-hidden="true"></i></a></li>
            <li class="twitter"><a href="https://twitter.com/IgemNous" target="_blank"><i class="fa fa-twitter"
                        aria-hidden="true"></i></a></li>
            <li class="instagram"><a href="https://www.instagram.com/nous_igem/" target="_blank"><i
                        class="fa fa-instagram" aria-hidden="true"></i></a></li>
            <li class="mail"><a href="mailto:igemnous@gmail.com" target="_blank"><i class="fa fa-envelope"
                        aria-hidden="true"></i></a></li>
            <li class="linkedin"><a href="https://www.linkedin.com/company/igem-nous" target="_blank"><i
                        class="fa fa-linkedin" aria-hidden="true"></i></a></li>
            <li class="youtube"> <a href="https://www.youtube.com/channel/UCVN2NQ_uRJVXhXU_FfvKlrg" target="_blank"><i
                        class="fa fa-youtube" aria-hidden="true"></i></a></li>
            <li class="github"><a href="https://github.com/melinazik/iGEM" target="_blank"><i class="fa fa-github"
                        aria-hidden="true"></i></a></li>
            <li class="website"><a href="https://igemnous.med.duth.gr/" target="_blank"><i class="fa fa-globe"
                        aria-hidden="true"></i></a></li>
        </ul>
        <br><br><br><br><br><br><br>
        <hr style="background-color: #E8E8E8;border: 1.5px solid #E8E8E8;opacity: 50%;">

        <br><br><br><br><br><br><br><br>


        <div style="display:flex;flex-wrap:wrap; ">
            <div class="col">
                <a href="https://igemnous.med.duth.gr/" target="_blank">
                    <img style=" position: relative;width: 40%;padding-bottom: 120px;margin-left: calc(100%/1.5);"
                        src="https://2021.igem.org/wiki/images/2/2f/T--Greece_United--black-logo-transp.png">
                </a>

            </div>

            <div style="display: flex;flex-direction: row;justify-content: center;bottom: 0%;">
                <div class="footer_sponsors"
                    style="display: flex;flex: 1;justify-content: center;align-items: center;padding-left: 1%;padding-right: 1%;">
                    <a href="https://duth.gr/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/5/5f/T--Greece_United--dimokriteio.png"
                            style="width:250%; margin-left: calc((100%)/0.09); margin-bottom: 290px; margin-top: -400px; "></a>
                    <a href="https://www.geneious.com/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/f/f9/T--Greece_United--geneious.png"
                            style="width:70%; margin-left: calc((100%)/0.45); margin-bottom: 250px; margin-top: -280px;"></a>
                    <a href="https://www2.deloitte.com/gr/en.html" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/0/07/T--Greece_United--deloitte.svg"
                            style="width:170%; margin-left: calc((100%)/0.31); margin-bottom: 290px; margin-top: -480px;"></a>
                    <a href="https://bioemtech.com/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/6/66/T--Greece_United--bioemtech.png"
                            style="width:40%; margin-left: calc((100%)/6.5); margin-bottom: -40px; margin-top: -320px;"></a>
                </div>
            </div>

        </div>



    </footer>

</body>

</html>